Molina Healthcare (MOH) director receives 317-share equity grant for Q1 2026

Rhea-AI Filing Summary

Molina Healthcare, Inc. reported that one of its directors received a grant of common stock as part of the company’s equity compensation program. On January 1, 2026, the director was granted 317 shares of Molina Healthcare common stock under the company’s 2025 Equity Incentive Plan for services as a director. The quarterly equity award was set at a dollar value of $55,000, determined by dividing that amount by the stock’s closing price of $173.54 on December 31, 2025, resulting in the 317-share grant. Following this transaction, the director beneficially owned 11,669 shares of Molina Healthcare common stock, held directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Schapiro Richard M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	317	$173.54	$55K

Holdings After Transaction: Common Stock — 11,669 shares (Direct)

Footnotes (1)

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock. Represents the closing price of the Issuer's common stock on December 31, 2025.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schapiro Richard M

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/01/2026		A(1)		317(2)	A	$173.54(3)	11,669	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. Since the grant date of January 1, 2026, was a non-trading day, the number of shares was calculated based on the closing price of the Issuer's common stock on December 31, 2025, of $173.54. Thus, the grant this quarter for services as a Director is for 317 shares of the Issuer's common stock.

3. Represents the closing price of the Issuer's common stock on December 31, 2025.

Remarks:

	Jeff D. Barlow, by power of attorney for Richard M. Schapiro.	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction was reported for Molina Healthcare (MOH)?

A director of Molina Healthcare, Inc. reported receiving a grant of 317 shares of the company’s common stock as equity compensation for board service.

How many Molina Healthcare (MOH) shares were granted and on what date?

The director was granted 317 shares of Molina Healthcare common stock with a grant date of January 1, 2026, as disclosed in the filing.

How was the number of shares in the Molina Healthcare (MOH) director grant calculated?

The quarterly equity award was set at $55,000, and the number of shares was calculated using the $173.54 closing price of Molina Healthcare common stock on December 31, 2025, resulting in 317 shares.

What equity compensation structure does Molina Healthcare (MOH) use for this director?

The filing states that the grant was made under the 2025 Equity Incentive Plan, with an annual director equity award of $220,000, of which one quarter ($55,000) is granted on the first day of each quarter.

How many Molina Healthcare (MOH) shares does the director own after this grant?

After the reported grant of 317 shares, the director beneficially owned 11,669 shares of Molina Healthcare common stock, held directly.

Did the Molina Healthcare (MOH) director report any derivative securities in this filing?

No derivative securities were reported in Table II; the disclosed transaction relates only to non-derivative common stock.

Was the Molina Healthcare (MOH) transaction a grant or a market purchase?

The filing explains that it was a grant of stock under the 2025 Equity Incentive Plan in connection with the director’s services, not an open-market purchase.